A child with leukemia is receiving triple intrathecal chemotherapy consisting of methotrexate, cytarabine, and hydrocortisone. The purpose of this is to prevent:

Question

Quizplus · Accepted Answer

The purpose of administering triple intrathecal chemotherapy with methotrexate, cytarabine, and hydrocortisone to a child with leukemia is to prevent central nervous system (CNS) disease. This approach targets potential or existing microscopic disease in the CNS, which is a common sanctuary site for leukemia cells where systemic chemotherapy may not effectively penetrate.

A Child with Leukemia Is Receiving Triple Intrathecal Chemotherapy Consisting